stretch of their 3′ end for strand-switching, are used. The first-strand cDNA generated in the first RT reaction (RT1) contains the mutated sequence and is present at the 5′ end of the first-strand cDNA linked to the universal primer U1. The RT1 reaction utilizes the mutagenic primer and one of the universal RT primers, U1. The first-strand cDNA generated in the second RT reaction (RT2) contains the full-length and nonmutant target gene with different universal binding sites at both ends. Universal RT primers U2 and U3 are used in RT2 (Figure 1, A1) . The full-length mutated target gene is produced and amplified in a one-tube two-step PCR as reported previously (5) . The universal primer U1 amplifies the sense strand of the cDNA of RT1 during the first PCR step (Figure 1, A2, step 1) . Having stopped the reaction, the RT2 product is added to the mixture. The sense strands carrying Cloning independent site-directed mutagenesis using total RNA as template 
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BENCHMARKS the mutation near the 3′ end hybridize to cDNAs of RT2 containing the fulllength and nonmutated antisense target gene and are elongated by the Taq DNA polymerase (Figure 1 , A3, step 2). In this way, an extra universal primer binding site is added to the 3′ end of the sense strand of the target gene. This sense strand contains the full-length mutated target gene with the same universal primer binding sequences at both ends (Figure 1, A4) . Finally, the mutated target gene is amplified with universal primer U1 (Figure 1 , A4, step 3). The nonmutated target gene cannot be amplified by the universal PCR primer, because it possesses only one PCR primer binding site. The RT-PCR products can be cloned into a "TA" cloning vector, such as pGEM ® -T (Promega, Madison, WI, USA), or both sides of the mutated target gene can be digested with one restriction enzyme and subsequently cloned into an appropriate vector. In the latter case, only those inserts that possess the same endonuclease sites at both ends and that contain the desired mutation will be cloned with high efficiency. If there are some aspecific (e.g., nonmutated) products in the RT-PCR, the RT-PCR products cannot be digested with this restriction enzyme (Figure 1, A5) , therefore only the mutant product can be cloned. To verify the introduced mutation, a new restriction binding site can be generated with the mutation.
To demonstrate our method, we have successfully introduced mutations into two human genes coding for α-synuclein (500 bp long) and prolylendopeptidase (2200 bp). Two different sizes were selected in order to determine whether there is any difference in reaction efficiency depending on the length of the cDNA product.
The primers used are shown in Table  1 . The RT reactions were carried out in a final volume of 20 μL. The RT1 reaction contained 5 μg human reference RNA (7), 3.5 pmol universal RT primer U1, 3.5 pmol mutagenic RT primer AS53R were cloned into pGEM-T Easy Vector System I (Promega). The mutant α-synuclein clones were digested with XbaI (MBI Fermentas, Vilnius, Lituania). The prolylendopeptidase clones were digested with XbaI and EcoRI (MBI Fermentas) for mutation verification. To determine the efficiency of the method, we screened 100 clones isolated from the mutagenesis of the prolyl-endopeptidase gene. Of these, 96 clones had the desired mutation, as assessed by restriction digest screening. Of the remaining four clones, two contained truncated forms, and two others had other inserts.
Furthermore, sequencing of three mutated synuclein and two mutated endopeptidase clones verified the mutation, and only one other mutation was 
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detected in the case of one endopeptidase clone, although it did not affect the primary sequence of the protein. This result is not surprising, considering Taq DNA polymerase was used. To reduce the risk of unwanted mutations, a high fidelity polymerase should be used. In the case of longer sequences, the generated clone should be sequence-verified for further studies. Because of the simplicity and costeffectiveness of the present protocol, we suggest this approach for studies in which numerous small to medium sized genes are to be mutated. The procedure avoids the purchase or creation of cDNA clones and results in high efficiency generation of the desired mutant.
